How to achieve the "best use" in the rising demand of biomedical personnel

[pharmaceutical network market analysis] in recent years, the occupational supply and demand of Yantai human resources market shows that the demand for personnel in the biomedical industry has increased The main positions are pharmaceutical representative, assistant researcher, researcher, R & D Manager, production process supervisor, test engineer, etc According to the recruitment requirements, biological talents should have considerable knowledge accumulation and medical and pharmaceutical professional background, strong understanding, communication and learning ability, be familiar with product development, have innovation ability, have certain market analysis and product positioning knowledge, and have the ability to lead the scientific research group independently It is understood that biomedical industry is a strategic emerging industry supported by the state With the acceleration of a new round of scientific and technological revolution and industrial change, endless new technologies, new formats and new models of biomedical industry have formed tremendous momentum, which has pushed the industry forward in depth Biomedical industry has become a new growth point of new economy, which is breeding and giving birth to a new industrial revolution So how do biomedical enterprises maintain competitiveness in the new market environment? How to innovate and upgrade the biomedical industry? The key is still the advanced talents In recent years, the biomedical industry has begun to vigorously promote the talent strategy Some insiders said that in the past five years, developed countries have made great breakthroughs in the field of immune tumor, and a large number of domestic pharmaceutical enterprises have been rapidly advancing Taking PD-1 as an example, there are five companies (approved) in the United States, two in China, and dozens behind In addition, China's medical reform has reduced the proportion of generic drugs in medicine through "4 + 7" volume procurement measures, so that medical insurance has more money to pay for innovative drugs All in all, China's major initiatives in healthcare and national pharmaceutical reform will enable the industry to continue to develop in the future "Companies are looking forward to innovative talents." It is reported in a report of the Wall Street Journal that Chinese Biomedical enterprises seeking to go global are poaching talents from large pharmaceutical companies in the United States, trying to open up new space for Chinese innovative drug R & D innovation and market expansion in the United States For example, Baiji Shenzhou, a representative Chinese bio innovation pharmaceutical company that cultivates and excavates talents in the United States, currently has more than 400 employees in the United States, with offices in Massachusetts, California and New Jersey It is worth noting that many of the more than 400 employees in Baiji have the experience of working in large pharmaceutical enterprises in the United States Biopharmaceutical industry is an industry with a high concentration of knowledge, capital and talents At present, the development prospect of biopharmaceutical industry is getting better and better, but the difficulty of finding talents seems to be the same problem faced by the industry In the future development, China needs to continue to strengthen institutional innovation, increase the code of reward support, accelerate talent gathering, so that high-level biomedical talents can be introduced, retained and used well In order to better attract and retain high-level biomedical talents, China has started to put into action For example, we have improved functional support, built supporting facilities for the convenience of people such as talent apartments, staff dormitories, supermarkets, etc., and set up warm-hearted activity places such as electronic reading room and staff home in the comprehensive building, striving to create a happy home for staff We should pay more attention to incentives and give more rewards and support We will set up two funds for talent development and innovation and entrepreneurship, build three platforms for R & D, entrepreneurship and innovation, and technology alliance, and promote the in-depth integration of industry, University, research and application "We have set up a 200 million yuan industrial development guidance fund to support or reward enterprises or talents who have made outstanding contributions to the development of the biomedical industry." Said the person in charge of a certain place In terms of talent introduction, more and more biomedical enterprises begin to attach great importance to it "The company has continuously strengthened cooperation with scientific research institutions, introduced talents, and ensured the uniqueness of products in the biomedical industry through measures such as improving product technology threshold and continuously developing new products." As the head of an enterprise said For enterprises, talent is the king of development In the face of the rapid development of biomedicine, China needs to attach great importance to scientific and technological innovation and talent introduction, and strive to create a talent development environment of "making the best use of talents".